Рынок средств для прекращения курения и избавления от никотиновой зависимости на Ближнем Востоке и в Африке – тенденции отрасли и прогноз до 2030 года

Анализ и размер рынка средств для прекращения курения и избавления от никотиновой зависимости на Ближнем Востоке и в Африке

Основными факторами, способствующими росту рынка прекращения курения и избавления от никотиновой зависимости в прогнозируемый период с 2023 по 2020 год, являются растущая распространенность многих целевых заболеваний, таких как сердечные заболевания, респираторные расстройства и рак легких, вызванные курением. Кроме того, внедрение новых продуктов для замены никотина для облегчения тяги к никотину также, как ожидается, повысит показатели проникновения этих продуктов. Новые продукты с минимальными побочными эффектами и улучшенным вкусом включают различные никотиновые жевательные резинки. Свежая мята, ледяная мята и свежие фрукты, вероятно, будут стимулировать рост рынка в предстоящие годы.

Компания Data Bridge Market Research анализирует, что рынок средств для прекращения курения и избавления от никотиновой зависимости, который в 2022 году составил 1 260,07 млн ​​долларов США, как ожидается, достигнет 9 251,43 млн долларов США к 2030 году, увеличившись в среднем на 28,30% в течение прогнозируемого периода с 2023 по 2030 год. Помимо информации о рыночных сценариях, таких как рыночная стоимость, темпы роста, сегментация, географический охват и основные игроки, рыночные отчеты, подготовленные компанией Data Bridge Market Research, также включают в себя углубленный экспертный анализ, географически представленное производство и мощности компаний, сетевые схемы дистрибьюторов и партнеров, подробный и обновленный анализ ценовых тенденций и анализ дефицита цепочки поставок и спроса.

Рынок средств для прекращения курения и избавления от никотиновой зависимости на Ближнем Востоке и в Африке: масштаб и сегментация

Market Definition

Smoking cessation or nicotine de-addiction comprises tobacco cessation, decreasing the risk of cancer and other serious health problems. Smoking comprises the use of tobacco which contain nicotine that generates addiction by releasing neurotransmitters in consumers such as dopamine, glutamate, Zyban, and gamma-aminobutyric acid (GABA). People who want to quit smoking can use nicotine replacement therapy, therapeutic medication such as nicotine receptors, and anti-depressants agonists such as varenicline and cytisine to treat tobacco dependency.

Middle East and Africa Smoking Cessation and Nicotine De-Addictions Market Dynamics

Drivers

• Increasing adoption of online retailing

The growing adoption of online retailing is expected to drive the growth of the smoking cessation and nicotine de-addiction market. With the growth of e-commerce businesses in the Middle East and Africa region, vendors can potentially improve their profitability. E-commerce and online channels support business-to-business and business-to-consumer operations. This trend encourages numerous manufacturers to focus on the online customer segment and supports vendors in reducing their operating and overhead costs. Moreover, the number of online drugstores and pharmacies offering nicotine patches and other nicotine replacement therapy products has developed considerably, driving the market growth during the forecast period.

• The growing number of people trying to quit smoking

One of the other major factors that are likely to drive the growth of the smoking cessation and nicotine de-addiction market is the growing number of people trying to quit smoking in the Middle East and Africa region. As a result of the toxic effects of cigarette and nicotine addiction on the respiratory systems and cardiac, increasing the popularity of smoking cessation and nicotine de-addiction is likely to boost the market growth.

Opportunities

• Undertaking new initiatives to encourage consumers to quit smoking

New marketing initiatives are the major factor likely to create lucrative opportunities for market growth. Vendors are undertaking new marketing initiatives and creating advertising campaigns that encourage consumers to quit smoking and increase their sales. For instance, JUUL launched its first television advertising campaign in 2019. This new campaign included testimonials from adults who have highly used JUUL products to quit smoking. Such marketing campaigns will increase the growth of the smoking cessation and nicotine de-addiction market during the forecast period.

• Increasing popularity of e-cigarettes

E-cigarettes are considered a healthy substitute for tobacco cigarettes over the forecast period. The growing popularity of e-cigarettes because of their electronic feature is considered the major factor likely to create lucrative opportunities for market growth. For instance, now e-cigarette products with a convenient rechargeable feature are being manufactured by major companies in the Middle East and Africa region, which will further boost the market growth.

Restraints/Challenges

• Growing awareness regarding health issues through the consumption of smoking cessation products

Growing awareness regarding health issues associated with consuming smoking cessation products, such as nicotine patches, lozenges, nicotine chewing gum, and e-cigarettes, may hamper the market growth during the forces period. Long-term usage of nicotine chewing gum can cause numerous health problems, such as elevated blood pressure, irregular heartbeat, insulin resistance, hair loss, skin irritation, gastrointestinal issues, and nausea which may challenge the market growth.

This smoking cessation and Nicotine de-addictions market report provide details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the smoking cessation and Nicotine de-addictions market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you make an informed market decision to achieve market growth.

Expected Impact of Economic Slowdown on the Pricing and Availability of Products

When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.

Recent Development

• 22nd Century Group, Inc.’s VLN King and VLN Menthol King cigarettes have become the world’s first and only combustible cigarettes to receive Modified Risk Tobacco Product (MRTP) authorization from the U.S. Food and Drug Administration (FDA)

Middle East and Africa Smoking Cessation and Nicotine De-Addictions Market Scope

The smoking cessation and nicotine de-addictions market is segmented on the basis of product type, treatment type, distribution channel and end-user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Drug therapy
• Nicotine Replacement Therapy (NRT)
• Sprays
• Inhalers
• chewing gum
•  Transdermal Patches
• Lozenges
•  Sublingual Tablets
• Electronic Cigarettes (E-Cigarette)

Treatment Type

• Pharmacological
• Therapies
• Others

Distribution Channel

• Online
• Offline
• Drug Stores and Retailers
• Hospital Pharmacies

End-User

• Generation Z
• Millennials
• Generation X
• Silent Generation

Middle East and Africa Smoking Cessation and Nicotine De-Addictions Market Regional Analysis/Insights

The smoking cessation and nicotine de-addictions market is analyzed, and market size insights and trends are provided by country, product type, treatment type, distribution channel and end-user as referenced above.

The countries covered in the smoking cessation and nicotine de-addictions market report are Saudi Arabia, the U.A.E, South Africa, Egypt, Israel, the Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. 

Competitive Landscape and Middle East and Africa Smoking Cessation and Nicotine De-Addictions Market Share Analysis

The smoking cessation and nicotine de-addictions market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to smoking cessation and the smoking cessation and nicotine de-addictions market.

Некоторые из основных игроков, работающих на рынке услуг по отказу от курения и избавлению от никотиновой зависимости:

• Imperial Brands (Великобритания)
• 22nd Century Group, Inc (США)
• Pfizer Inc. (США)
• Reddy's Laboratories Ltd (Индия)
• GlaxoSmithKline Plc. (Великобритания)
• British American Tobacco (Великобритания)
• Корпорация Cambrex (США)
• Cipla Inc. (США)
• Fertin Pharma (Дания)
• Johnson & Johnson частная компания с ограниченной ответственностью (США)
• Perrigo Company Plc (Ирландия)

SKU-53228